<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>27(6)</volume><submitter>Lara Gutierrez A</submitter><pubmed_abstract>Genomic instability scars are markers for detecting homologous recombination deficiency (HRD) status in patients with ovarian cancer and predicting the response to poly (ADP-ribose) polymerase inhibitor treatment. Currently, only a few reliable and validated assays are available, with the Myriad myChoice CDx being the most commonly used commercial assay for genomic instability scar score determination. Given the need for a more straightforward, accessible, and reliable method for detecting genomic instability scars methods, in this work, we describe the feasibility of using the microarray OncoScan copy number variant assay and open-source software packages to quantify genomic instability scores, and the development of an open-access online platform for genomic instability score calculation</pubmed_abstract><journal>The Journal of molecular diagnostics : JMD</journal><pagination>475-484</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12163384</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Robust Assessment of Homologous Recombination Deficiency Genomic Instability by OncoScan Microarrays.</pubmed_title><pmcid>PMC12163384</pmcid><pubmed_authors>Peternell C</pubmed_authors><pubmed_authors>Kashofer K</pubmed_authors><pubmed_authors>Lara Gutierrez A</pubmed_authors><pubmed_authors>Regitnig P</pubmed_authors><pubmed_authors>Petru E</pubmed_authors><pubmed_authors>Halbwedl I</pubmed_authors><pubmed_authors>Bodo K</pubmed_authors><pubmed_authors>Prein K</pubmed_authors><pubmed_authors>Seebock R</pubmed_authors><pubmed_authors>Sauer S</pubmed_authors><pubmed_authors>Schubert S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Robust Assessment of Homologous Recombination Deficiency Genomic Instability by OncoScan Microarrays.</name><description>Genomic instability scars are markers for detecting homologous recombination deficiency (HRD) status in patients with ovarian cancer and predicting the response to poly (ADP-ribose) polymerase inhibitor treatment. Currently, only a few reliable and validated assays are available, with the Myriad myChoice CDx being the most commonly used commercial assay for genomic instability scar score determination. Given the need for a more straightforward, accessible, and reliable method for detecting genomic instability scars methods, in this work, we describe the feasibility of using the microarray OncoScan copy number variant assay and open-source software packages to quantify genomic instability scores, and the development of an open-access online platform for genomic instability score calculation</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jun</publication><modification>2025-07-26T03:07:26.222Z</modification><creation>2025-07-26T03:07:26.222Z</creation></dates><accession>S-EPMC12163384</accession><cross_references><pubmed>40188947</pubmed><doi>10.1016/j.jmoldx.2025.02.011</doi></cross_references></HashMap>